{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009066","form_type":"8-K","ticker":"DWTX","cik":"0001818844","company_name":"Dogwood Therapeutics, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.339347+00:00","generated_at":"2026-06-01T04:53:29.761876+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Virios Therapeutics granted Nasdaq exception until Oct 28, 2024 to regain $1.00 bid price compliance","bullets":["Nasdaq Hearing Panel grants exception until October 28, 2024 to meet minimum $1.00 bid price rule.","If not compliant by October 11, 2024, Company must pursue a reverse stock split by the deadline.","Failure to regain compliance by October 28, 2024 will result in delisting from Nasdaq Capital Market.","Initial deficiency notice was received November 7, 2023; prior 180-day cure period expired April 30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009066","json":"https://secwatch.observer/filing/0001558370-24-009066.json","markdown":"https://secwatch.observer/filing/0001558370-24-009066.md","text":"https://secwatch.observer/filing/0001558370-24-009066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818844/000155837024009066/0001558370-24-009066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818844/000155837024009066/viri-20240611x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:53:29.761876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}